Pancreatic Cancer Research

ResearcherUniversity of KansasActive in the last 2 years

Stefan H. Bossmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0058-0127; OpenAlex author ID A5048246567. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cells. Co-author DOI 10.1016/j.omton.2025.201047↗
  2. Protease activity-based nanobiosensors for early detection of pancreatic cancer. Last author DOI 10.18103/mra.v12i7.5632↗
  3. In Vitro Measurement and Mathematical Modeling of Thermally-Induced Injury in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers15030655↗
  4. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. Co-author DOI 10.3390/ijms24076336↗
  5. A New Hope for Liquid Biopsies: Early Detection of Pancreatic Cancer By Means of Protease Activity Detection in Serum Applying a Hierarchical Decision Structure Last author DOI 10.1101/2022.10.18.22281240↗
  6. Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy. Co-author DOI 10.18053/jctres.07.202102.008↗
  7. A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model. Co-author DOI 10.1002/smll.201101879↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anup Kasi · 4 shared papers, 2021–2024 · strength 0.68
  2. Obdulia Covarrubias‐Zambrano · 3 shared papers, 2022–2024 · strength 0.54
  3. Prasad R. Dandawate · 2 shared papers, 2021–2023 · strength 0.30
  4. Shrikant Anant · 2 shared papers, 2021–2023 · strength 0.30
  5. Matthew T. Basel · 2 shared papers, 2012–2023 · strength 0.23
  6. Mohiuddin Quadir · 1 shared paper, 2025 · strength 0.22
  7. Debasmita Dutta · 1 shared paper, 2025 · strength 0.22
  8. Daniel J. Mettman · 1 shared paper, 2025 · strength 0.22
  9. Sushanta K. Banerjee · 1 shared paper, 2025 · strength 0.22
  10. Snigdha Banerjee · 1 shared paper, 2025 · strength 0.22
  11. Faraz Chamani · 1 shared paper, 2023 · strength 0.19
  12. Punit Prakash · 1 shared paper, 2023 · strength 0.19
  13. Sangita Bhattacharyya · 1 shared paper, 2023 · strength 0.16
  14. Subhash Padhyé · 1 shared paper, 2023 · strength 0.16
  15. Michael Nathan VanSaun · 1 shared paper, 2023 · strength 0.16
  16. Weijing Sun · 1 shared paper, 2021 · strength 0.14
  17. Jessica Allen · 1 shared paper, 2021 · strength 0.14
  18. Deryl L. Troyer · 1 shared paper, 2012 · strength 0.03
  19. Masaaki Tamura · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.